Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jan 3;14(1):216. doi: 10.3390/cancers14010216

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Kaplan–Meier survival curves and the log-rank test for the most optimal prognostic models: (A) the combination of pretreatment, intratreatment and delta parameters for the cumulative incidence of locoregional recurrence, divided into high/medium/low risk groups; (B) prediction model with pretreatment parameters for the cumulative incidence for distant metastasis, divided into high/medium/low risk groups; and (C) prediction model with pretreatment parameters prognostic for overall survival, divided into high/medium/low risk groups.

Kaplan–Meier survival curves and the log-rank test for the most optimal prognostic models: (A) the combination of pretreatment, intratreatment and delta parameters for the cumulative incidence of locoregional recurrence, divided into high/medium/low risk groups; (B) prediction model with pretreatment parameters for the cumulative incidence for distant metastasis, divided into high/medium/low risk groups; and (C) prediction model with pretreatment parameters prognostic for overall survival, divided into high/medium/low risk groups.